(Q67902984)
Statements
"Classical" CMF versus a 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancer. An EORTC Breast Cancer Co-operative Group Phase III Trial (10808) (English)
E Engelsman
J C Klijn
R D Rubens
J Wildiers
L V Beex
M A Nooij
N Rotmensz
R Sylvester
1 January 1991